ALLTAQ Trademark

Trademark Overview


On Friday, October 13, 2017, a trademark application was filed for ALLTAQ with the United States Patent and Trademark Office. The USPTO has given the ALLTAQ trademark a serial number of 79227907. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by Qiagen GmbH. The ALLTAQ trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the ...

Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely, buffer solutions used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
alltaq

General Information


Serial Number79227907
Word MarkALLTAQ
Filing DateFriday, October 13, 2017
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5790162
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely, buffer solutions used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 5, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, March 9, 2018APPLICATION FILING RECEIPT MAILED
Thursday, March 1, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 5, 2018ASSIGNED TO EXAMINER
Monday, March 12, 2018NON-FINAL ACTION WRITTEN
Tuesday, March 13, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 19, 2018REFUSAL PROCESSED BY MPU
Monday, March 19, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 6, 2018REFUSAL PROCESSED BY IB
Monday, September 17, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 17, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, October 29, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018ASSIGNED TO PETITION STAFF
Saturday, November 24, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 27, 2018APPLICANT SUPPLIED CHANGES/CORRECTIONS AFTER PUB APPROVAL NOT ENT
Tuesday, December 11, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, March 22, 2019LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 14, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 23, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 19, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 20, 2019REFUSAL PROCESSED BY IB
Monday, June 17, 2019LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, October 19, 2019FINAL DISPOSITION PROCESSED
Friday, November 8, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 13, 2020LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, January 24, 2020LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, December 5, 2020FINAL DECISION TRANSACTION PROCESSED BY IB